If approved, the Opdivo-based regimen would be the first immunotherapy-chemotherapy combination approved for this patient population in the EU
Additional data in pregnant adults who are Virologically suppressed reinforce safety and tolerability profile of Biktarvy in broad range of people with HIV
Sales reflect continued strong growth in oncology and vaccines
Open a printable version of this pageEmail the URL of this page to a friend
NexGard Spectra is a soft, flavourful monthly chew that kills fleas before they can lay eggs
Longest survival follow-up ever reported for immunotherapy treatment in this setting
Abecma tripled progression-free survival compared to standard regimens in the Phase 3 KarMMa-3 trial
Decision marks the first approval in Europe for an anti-PD-1/L1 therapy in resectable NSCLC based on positive overall survival results
To accelerate the development of next-generation radioconjugates to treat cancer
Cureskin aims to disrupt the large and growing skin and hair care industry in India
Subscribe To Our Newsletter & Stay Updated
